MHC–peptide specificity and T-cell epitope mapping: where immunotherapy starts
- 1 October 2006
- journal article
- Published by Elsevier in Trends in Molecular Medicine
- Vol. 12 (10) , 465-472
- https://doi.org/10.1016/j.molmed.2006.08.008
Abstract
No abstract availableKeywords
This publication has 69 references indexed in Scilit:
- Workshop on Cancer Biometrics: Identifying Biomarkers and Surrogates of Cancer in PatientsJournal of Immunotherapy, 2005
- Induction of Endothelial Nitric Oxide Synthase Expression by Melanoma Sensitizes Endothelial Cells to Tumor Necrosis Factor-Driven CytotoxicityClinical Cancer Research, 2004
- Identification of a small peptide that inhibits the phosphorylation of ErbB2 and proliferation of ErbB2 overexpressing breast cancer cellsInternational Journal of Cancer, 2004
- Use of a lentiviral vector encoding a HCMV-Chimeric IE1-pp65 protein for epitope identification in HLA-Transgenic mice and for ex vivo stimulation and expansion of CD8+ cytotoxic T cells from human peripheral blood cellsHuman Immunology, 2004
- The matrix protein pp65341‐350: a peptide that induces ex vivo stimulation and in vitro expansion of CMV‐specific CD8+ T cells in subjects bearing either HLA‐A*2402 or A*0101 alleleTransfusion, 2003
- Functional leukemia-associated antigen-specific memory CD8+ T cells exist in healthy individuals and in patients with chronic myelogenous leukemia before and after stem cell transplantationBlood, 2003
- Cytomegalovirus-specific cytolytic T-cell lines and clones generated against adenovirus-pp65-infected dendritic cellsTransplantation and Cellular Therapy, 2001
- Frequencies of HLA-A2 alleles in five U.S. population groups: Predominance of A∗02011 and identification of HLA-A∗0231Published by Elsevier ,2000
- Differential binding of viral peptides to HLA-A2 alleles. Implications for human papillomavirus type 16 E7 peptide-based vaccination against cervical carcinomaEuropean Journal of Immunology, 1999
- Antigen processing and presentationTissue Antigens, 1996